Searching the RRID Resource Information Network
Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
SciCrunch Registry is a curated repository of scientific resources, with a focus on biomedical resources, including tools, databases, and core facilities - visit SciCrunch to register your resource.
| Resource Name | Proper Citation | Abbreviations | Resource Type |
Description |
Keywords | Resource Relationships | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
GSE4922 Resource Report Resource Website 100+ mentions |
GSE4922 (RRID:SCR_003557) | GSE4922 | data or information resource, data set | Curated data set of a study that investigated the expression profiles of 347 primary invasive breast tumors on Affymetrix microarrays. Three separate breast cancer cohorts were analyzed: 1) Uppsala (n=249), 2) Stockholm (n=58), 3) Singapore (n=40). The Uppsala and Singapore data can be accessed in GSE4922. The Stockholm cohort data can be accessed at GEO Series GSE1456. | adult human, expression profile, breast |
is related to: Gene Expression Omnibus has parent organization: RanchoBiosciences |
Cancer, Breast cancer, Tumor | Free, Public | nlx_157796 | SCR_003557 | 2026-02-14 02:07:52 | 110 | |||||||
|
Strelka Resource Report Resource Website 100+ mentions |
Strelka (RRID:SCR_005109) | Strelka | software resource, commercial organization | THIS RESOURCE IS NO LONGER IN SERVICE. Documented on March 7,2024. Software for somatic single nucleotide variant (SNV) and small indel detection from sequencing data of matched tumor-normal samples. The method employs a novel Bayesian approach which represents continuous allele frequencies for both tumor and normal samples, whilst leveraging the expected genotype structure of the normal. This is achieved by representing the normal sample as a mixture of germline variation with noise, and representing the tumor sample as a mixture of the normal sample with somatic variation. A natural consequence of the model structure is that sensitivity can be maintained at high tumor impurity without requiring purity estimates. The method has superior accuracy and sensitivity on impure samples compared to approaches based on either diploid genotype likelihoods or general allele-frequency tests. | single nucleotide variant, indel, somatic snv, next-generation sequencing, bio.tools |
is listed by: Debian is listed by: bio.tools is listed by: SoftCite has parent organization: Illumina |
Cancer, Tumor, Normal | PMID:22581179 PMID:30013048 |
biotools:strelka | https://bio.tools/strelka https://github.com/Illumina/strelka/ https://sources.debian.org/src/strelka/ |
SCR_005109 | 2026-02-14 02:07:51 | 261 | ||||||
|
Fred Hutchinson Cancer Research Center Co-operative Center for Excellence in Hematology Scientific Imaging Resource Report Resource Website |
Fred Hutchinson Cancer Research Center Co-operative Center for Excellence in Hematology Scientific Imaging (RRID:SCR_015340) | core facility, access service resource, service resource | THIS RESOURCE IS NO LONGER IN SERVICE.Documented on July 27,2022. Scientific imaging service that serves as a centralized facility for imaging and visualization. The core facility provides access to time lapse and 3-D microscopy and quantitative autoradiography. | scientific imaging service, imaging, visualization, time lapse, 3d microscopy, autoradiography |
is listed by: NIDDK Information Network (dkNET) has parent organization: Fred Hutchinson Cancer Center is organization facet of: Fred Hutchinson Cancer Research Center Co-operative Center for Excellence in Hematology |
cancer | NIDDK P30DK056465 | THIS RESOURCE IS NO LONGER IN SERVICE | SCR_015340 | 2026-02-14 02:08:03 | 0 | ||||||||
|
Fred Hutchinson Cancer Research Center Co-operative Center for Excellence in Hematology Comparative Medicine Resource Report Resource Website |
Fred Hutchinson Cancer Research Center Co-operative Center for Excellence in Hematology Comparative Medicine (RRID:SCR_015326) | core facility, access service resource, service resource | THIS RESOURCE IS NO LONGER IN SERVICE.Documented on July 27,2022. Core facility that provides a variety of animal housing, veterinary and research support services. | comparative medicine, animal housing, veterinanary resource |
is listed by: NIDDK Information Network (dkNET) has parent organization: Fred Hutchinson Cancer Center is organization facet of: Fred Hutchinson Cancer Research Center Co-operative Center for Excellence in Hematology |
cancer | NIDDK P30DK056465 | THIS RESOURCE IS NO LONGER IN SERVICE | SCR_015326 | 2026-02-14 02:07:56 | 0 | ||||||||
|
Fred Hutchinson Cancer Research Center Co-operative Center for Excellence in Hematology Genomics Shared Resource Resource Report Resource Website |
Fred Hutchinson Cancer Research Center Co-operative Center for Excellence in Hematology Genomics Shared Resource (RRID:SCR_015327) | core facility, access service resource, service resource | THIS RESOURCE IS NO LONGER IN SERVICE.Documented on July 27,2022. Core facility that provides expertise and support for generating genomics-based data. Services for DNA arrays, genetic analysis, and high-throughput screening are provided through three specialized laboratories. | genomics core, dna array services, genetic analysis services, high throughput screening services |
is listed by: NIDDK Information Network (dkNET) has parent organization: Fred Hutchinson Cancer Center is organization facet of: Fred Hutchinson Cancer Research Center Co-operative Center for Excellence in Hematology |
cancer | NIDDK P30DK056465 | THIS RESOURCE IS NO LONGER IN SERVICE | SCR_015327 | 2026-02-14 02:08:28 | 0 | ||||||||
|
Karmanos Cancer Institute Resource Report Resource Website |
Karmanos Cancer Institute (RRID:SCR_000508) | Karmanos | data or information resource, portal | Center for patient care, education and research on cancer. The institute focuses its research on prevention methods, early detection, treatment and finding cures. | cancer, research, education, prevention, early detection, treatment, patient, care |
has parent organization: Wayne State University; Michigan; USA is parent organization of: JP McCarthy Cord Stem Cell Bank |
Cancer | NCI | Public | nlx_143656 | SCR_000508 | Karmanos Cancer Center, Barbara Ann Karmanos Cancer Institute, Barbara Ann Karmanos Cancer Center | 2026-02-14 02:05:00 | 0 | |||||
|
DCTD Resource Report Resource Website 10+ mentions |
DCTD (RRID:SCR_004196) | DCTD | data or information resource, funding resource, portal | Division of NCI that takes prospective cancer detection and treatment leads, facilitates their paths to clinical application, and expedites the initial and subsequent large-scale testing of new agents, biomarkers, imaging tests, and other therapeutic interventions (radiation, surgery, immunotherapy) in patients. DCTD, like all of NCI, supports many programs that could not be done without government funding - investigators supported by the division engage in scientifically sound, high-risk research that may yield great benefits for patients with cancer, but are too difficult or risky for industry or academia to pursue. This includes a particular emphasis on the development of distinct molecular signatures for cancer, refined molecular assays, and state-of-the-art imaging techniques that will guide oncologic therapy in the future. The division has eight major programs that work together to bring unique molecules, diagnostic tests, and therapeutic interventions from the laboratory bench to the patient bedside: * Cancer Diagnosis Program * Cancer Imaging Program * Cancer Therapy Evaluation Program * Developmental Therapeutics Program * Radiation Research Program * Translational Research Program * Biometrics Research Branch * Office of Cancer Complementary and Alternative Medicine | treatment, diagnosis, molecule, diagnostic test, therapeutic intervention |
is listed by: OMICtools has parent organization: National Cancer Institute is parent organization of: CDP |
Cancer | NCI | OMICS_01537 | SCR_004196 | Division of Cancer Treatment and Diagnosis | 2026-02-14 02:05:19 | 18 | ||||||
|
National Genome Research Network Resource Report Resource Website 10+ mentions |
National Genome Research Network (RRID:SCR_006626) | NGFN | data or information resource, organization portal, portal | The program of medical genome research is a large-scale biomedical research project which extends the national genome research net (NGFN) and will be funded by the federal ministry of education and research (BMBF) from 2008-2013. Currently the program includes two fields: * Research ** NGFN-Plus: With the aim on combating diseases that are central to health policy, several hundred researchers are systematically investigating the complex molecular interactions of the human body. They are organized in 26 Integrated Genome Research Networks. * Application ** NGFN-Transfer: The rapid transfer of results from medical genome research into medical and industrial application is the aim of the scientists from research institutes and biomedical enterprises that cooperate in eight Innovation Alliances. AREAS OF DISEASE * Cardiovascular disease * Cancer * Neuronal diseases * Infections and Inflammations * Environmental factors | genome, research, gene, disease | Cardiovascular disease, Cancer, Neuronal disease, Infectious disease, Inflammation, Disease linked to environment | BMBF | nlx_151595 | SCR_006626 | NGFN - National Genome Research Network, German National Genome Research Network | 2026-02-14 02:05:30 | 26 | |||||||
|
Central England Haemato-Oncology Research Biobank Resource Report Resource Website |
Central England Haemato-Oncology Research Biobank (RRID:SCR_004637) | CEHRB | biomaterial supply resource, cell repository, material resource | The Central England Haemato-Oncology Research Biobank stores excess material from oncology samples referred for diagnostic testing and disease monitoring at the West Midlands Regional Genetics Laboratory (WMRGL). The bank is housed within the WMRGL. Types of material stored include viable cells, fixed cell suspensions, DNA, RNA / cDNA, and plasma. The material is made available to all cancer research groups both locally and nationally. Excess sample (mainly from blood and bone marrow) is stored from diagnostic patient material and from samples received throughout their disease course. The WMRGL serves a population of about 5.5 million and is the largest UK NHS genetic Lab. Due to the large patient population CEHRB is able to collate sufficient research material from all classifications of neoplastic haematological disorders including those that are rare. | rare, ontology, hematology, tumor, oncology | is listed by: One Mind Biospecimen Bank Listing | Cancer, Neoplastic hematological disorder | Public: The material is made available to all cancer research groups both locally and nationally. | nlx_63387 | http://www.bwhct.nhs.uk/genetics-index/reglab_oncology.htm, http://www.bwhct.nhs.uk/genetics-index/central_england_haemato-oncology_research_biobank.htm | SCR_004637 | Central England Haemato-Oncology Research Biobank (CEHRB) | 2026-02-14 02:05:28 | 0 | |||||
|
Wistar Institute Collection at Coriell Resource Report Resource Website |
Wistar Institute Collection at Coriell (RRID:SCR_004660) | Wistar Collection | biomaterial supply resource, cell repository, material resource | Collection of cell lines developed by Wistar scientists that includes a group of hybridomas that produce monoclonal antibodies that are useful in influenza research and vaccine development, melanoma cell lines derived from patients with diseases ranging from mild dysplasia to advanced metastatic cancer and a range of human endothelial cell lines. | hybridoma, monoclonal antibody, antibody, cell line, melanoma cell line, endothelial cell line, smooth muscle cell line, disease, cancer, dysplasia, metastatic cancer |
is listed by: One Mind Biospecimen Bank Listing has parent organization: Coriell Cell Repositories has parent organization: Wistar Institute |
Disease, Cancer, Dysplasia, ( Diseases ranging from mild dysplasia to advanced metastatic cancer ) | Non-commercial, For research conducted by universities, Government agencies and academic research centers, Commercial with license | nlx_143856 | SCR_004660 | 2026-02-14 02:05:20 | 0 | |||||||
|
TumorSim Resource Report Resource Website 1+ mentions |
TumorSim (RRID:SCR_002604) | software resource, simulation software, software application | Simulation software that generates pathological ground truth from a healthy ground truth. The software requires an input directory that describes a healthy anatomy (anatomical probabilities, mesh, diffusion tensor image, etc) and then outputs simulation images. | clinical neuroinformatics, magnetic resonance, mri, brain, segmentation, simulation, tumor, ground truth |
uses: BrainWeb - Simulated Brain Database is listed by: NeuroImaging Tools and Resources Collaboratory (NITRC) has parent organization: University of Utah; Utah; USA |
Cancer | NIBIB R01 EB000219 | PMID:19119055 | Free, Available for download, Freely available | nlx_156007 | SCR_002604 | 2026-02-14 02:04:45 | 1 | ||||||
|
SEER Datasets and Software Resource Report Resource Website 10+ mentions |
SEER Datasets and Software (RRID:SCR_003293) | portal, data or information resource, software resource, disease-related portal, topical portal | Portal provides SEER research data and software SEER*Stat and SEER*Prep. SEER incidence and population data associated by age, sex, race, year of diagnosis, and geographic areas can be used to examine stage at diagnosis by race/ethnicity, calculate survival by stage at diagnosis, age at diagnosis, and tumor grade or size, determine trends and incidence rates for various cancer sites over time. SEER releases new research data every Spring based on the previous November’s submission of data. | NCI, cancer, statistics, epidemiology, analysis |
lists: SEER*Stat lists: NCI SEER Cancer Stage Variable Documentation is related to: Surveillance Epidemiology and End Results has parent organization: National Cancer Institute |
cancer | NCI | Free, Freely available | nif-0000-31490 | SCR_003293 | The Surveillance Epidemiology and End Results (SEER) Program, SEER Datasets Software, SEER Datasets & Software, The Surveillance Epidemiology and End Results (SEER) Program of the National Cancer Institute | 2026-02-14 02:04:29 | 28 | ||||||
|
Hyper Cell Line Database Resource Report Resource Website |
Hyper Cell Line Database (RRID:SCR_007730) | HyperCLDB | biomaterial supply resource, tissue bank, material resource | Hypertext on cell culture availability extracted from the Cell Line Data Base of the Interlab Project. HyperCLDB includes links to records of OMIM, the Online Mendelian Inheritance in Man Catalogue, and now also links to the PubMed, database of bibliographic biomedical references, which are drawn primarily from MEDLINE and PREMEDLINE. | cell, cell line, tumor, tissue, organ, blood, bodily fluid, ascitic fluid, brain, bone marrow, cancer, transforming agent, software, bio.tools |
is listed by: One Mind Biospecimen Bank Listing is listed by: 3DVC is listed by: Debian is listed by: bio.tools is related to: ATCC is related to: Cell Line Knowledge Base has parent organization: IST National Institute for Cancer Research; Genoa; Italy |
Cancer, Etc. | PMID:18927105 | nif-0000-03004, biotools:hypercldb | https://bio.tools/hypercldb | SCR_007730 | 2026-02-14 02:06:30 | 0 | ||||||
|
MPDB - Molecular Probe Database Resource Report Resource Website |
MPDB - Molecular Probe Database (RRID:SCR_007808) | MPDB | data or information resource, database | A database containing information on ca. 4300 synthetic oligonucleotides with a sequence of up to 100 nucleotides. Data are mainly taken from the literature and are encoded on the basis of controlled vocabularies. The probes target 821 different genes, of which 691 human and 112 viral. The probes can be used for genetic polymorphisms study (1944), human inherited disease diagnosis (834), cancer diagnosis (517), infectious disease diagnosis (517), neurologic disease diagnosis (72), autoimmune disease diagnosis (40). Oligonucleotides are described on the basis of: name, oligo type (primer, probe, antisense), nucleotide sequence, amino acid sequence (if part of a coding region), target gene and related infos (localization within the gene and recognized variants or specificities), applications, methods, technical notes, complementary primer (if used for PCR), primers for amplification (if probe), bibliographic references. At the moment MPDB is searchable through some SRS servers. MPDB can easily be retrieved from our FTP server, together with SRS syntax files. Typology * ca. 4300 oligonucleotides * 821 different genes, of which 691 human and 112 viral * ca. 3536 oligonucleotides are human gene specific * ca. 620 oligonucleotides are viral gene specific | molecular probe, synthetic oligonucleotide, molecule, probe, synthetic, oligonucleotide, nucleotide sequence, amino acid sequence, oligo probe, oligo dna, pcr primer, virus | has parent organization: IST National Institute for Cancer Research; Genoa; Italy | Genetic polymorphism, Inherited disease, Infectious disease, Neurologic disease, Autoimmune disease, Cancer | PMID:9399819 PMID:9016509 PMID:8594603 PMID:7937049 PMID:8332523 PMID:1598231 |
nif-0000-03165 | SCR_007808 | Molecular Probe Data Base (MPDB), Molecular Probe Data Base, Molecular Probe Database | 2026-02-14 02:06:39 | 0 | ||||||
|
Harvard Medical School Center for Cancer Systems Pharmacology Resource Report Resource Website |
Harvard Medical School Center for Cancer Systems Pharmacology (RRID:SCR_022831) | CCSP | data or information resource, organization portal, portal | Center includes studies for responsiveness and resistance to anti cancer drugs. Committed to training students and postdocs, promoting junior faculty and ensuring that data and software are reproducible, reliable and publicly accessible. Member of National Cancer Institute’s Cancer Systems Biology Consortium. | anti cancer drugs, responsiveness and resistance, National Cancer Institute, Systems Biology Consortium. | has parent organization: Harvard University; Cambridge; United States | Cancer, Melanoma, Triple negative breast cancer (TNBC), Glioblastoma multiforme (GBM) | NCI U54 CA225088 | Free, Freely available | SCR_022831 | Center for Cancer Systems Pharmacology | 2026-02-14 02:05:46 | 0 | ||||||
|
Creative Biogene Mitochondrial Gene Mutations Resource Report Resource Website |
Creative Biogene Mitochondrial Gene Mutations (RRID:SCR_022082) | data or information resource, organization portal, portal, service resource | Creative Biogene provides comprehensive range of services and products to assist researchers in cancer related mitochondria studies. Offers tests and services with advantage of cell based and animal based models. | Mitochondrial gene mutations, Creative Biogene, cancer related mitochondria studies | cancer | Restricted | SCR_022082 | 2026-02-14 02:05:45 | 0 | ||||||||||
|
Ohio State Leukemia Tissue Bank Resource Report Resource Website |
Ohio State Leukemia Tissue Bank (RRID:SCR_000529) | LTBSR | biomaterial supply resource, tissue bank, material resource | The OSU Comprehensive Cancer Center Leukemia Tissue Bank Shared Resource (LTBSR) facilitates the successful translation of basic leukemia research to the clinical setting via an extensive repository of tissue samples and accompanying pathologic, cytogenetic and clinical data for ready correlation of clinical and biological results. The LTBSR, which is an NCI-sponsored biorepository, has more than 40,000 vials of cryopreserved viable cells and 13,000 vials of matched frozen plasma and/or serum samples from more than 4,000 patients treated for leukemia and other malignancies. Committed to furthering translational research efforts for OSUCCC - James members and the cancer research community, the LTBSR provides investigators with training and technical support as well as procurement, processing, storage, retrieval and distribution of clinical research materials. In many cases, the LTBSR serves as the central processing lab for multi-site trials in which the principal investigator is an OSUCCC - James member. The LTBSR's goals are to: * Provide a central collection, processing and a state-of-the-art repository for samples collected from leukemia patients treated on OSUCCC - James protocols, and * Provide materials to investigators involved in collaborative studies with OSU, who examine relevant cellular and molecular properties of leukemia and correlate these properties with clinical or population-based outcomes. | leukemia, tissue, plasma, serum, cell, cells, viable cells, cryopreserved viable cells, pathologic data, cytogenetic data, clinical data, frozen, cryopreserved, malignancy, cancer |
is listed by: One Mind Biospecimen Bank Listing has parent organization: OSUCCC-James |
Leukemia, Cancer | NCI 2P30CA016058-40 | THIS RESOURCE IS NO LONGER IN SERVICE | nlx_55663 | http://www.osuccc.osu.edu/11167.cfm | SCR_000529 | OSUCCC Leukemia Tissue Bank Shared Resource, OSUCCC LTBSR, OSU Comprehensive Cancer Center Leukemia Tissue Bank Shared Resource | 2026-02-14 02:05:58 | 0 | ||||
|
Tumorbank Basel Foundation Resource Report Resource Website |
Tumorbank Basel Foundation (RRID:SCR_004962) | Tumorbank Basel Foundation | biomaterial supply resource, tissue bank, material resource | Since 1995 the Tumorbank Basel Foundation (German: Stiftung Tumorbank Basel) is a non-for-profit foundation acting in cancer translation research. The purpose of the Tumorbank Basel Foundation is to support in promoting optimization of decision making process for the management of solid cancer personalized treatment modalities to the benefit of the patient. Our Aims: * Acquisition and storage of biological material and clinical data of patients suffering of solid cancer diseases in particular breast and prostate cancer. * Promoting and supporting cancer research using the acquired material and data for clinical studies and translational research. * The development of molecular tumor analyses / tools for cancer patients and the performance of the resulting diagnostic services for personalized treatment modalities. The Tumorbank Basel Foundation has acquired * Data about more than 10''000 breast cancer patients * Data comprise clinical and pathological (histology & IHC) characteristics and biochemical (continuous quantified protein expression levels) features, which are available for almost all samples as well as clinical follow-ups now available for more than 2''000 patients * The RNA expression level of 65 genes has been assessed in >800 samples by Real-Time PCR (317 retrospectively in cases with follow-up, the remaining on a routine basis, prospectively since 2004) The Tumorbank Basel Foundation is storing in Freezers at - 80 degrees C * Ca. 6''000 fresh frozen tissue samples of breast cancer patients * Ca. 9''000 particulate fractions (cytosol / membrane) of all samples analyzed * Ca. 1''000 paired non-malignant adjacent tissue material samples * More than 1''000 extracted RNA samples of good quality * Serum and plasma collection from patients has been started since 2005 All data are stored in a relational SQL data bank using an application. The Tumorbank Basel Foundation is collaborating with several pathology institutes allowing to perform studies correlating results obtained from fresh frozen and paired paraffin embedded tissue samples. The Tumorbank Basel Foundation has started a prostate carcinoma project in Collaboration with the ZeTuP (www.zetup.ch) and pathology institute of St. Gallen. Fresh frozen samples of more than 150 prostate carcinoma patients have been collected and are under investigation. | tissue, tumor tissue, serum, plasma, rna, particulate fraction, clinical data, frozen, fresh frozen, paraffin embedded, cancer, breast cancer, prostate cancer, solid cancer disease | is listed by: One Mind Biospecimen Bank Listing | Cancer, Breast cancer, Prostate cancer, Solid cancer disease | Collaborators: The Tumorbank Basel Foundation is collaborating with several pathology institutes allowing to perform studies correlating results obtained from fresh frozen and paired paraffin embedded tissue samples. | nlx_143986 | SCR_004962 | Stiftung Tumorbank Basel | 2026-02-14 02:05:54 | 0 | ||||||
|
World BioBank Resource Report Resource Website |
World BioBank (RRID:SCR_004958) | World BioBank | biomaterial supply resource, tissue bank, material resource | Founded by the physician partners of ACORN, Inc. (Accelerated Community Oncology Research Network), World BioBank embraces forward-thinking technology and a strong commitment to the advancement of bioscience. The World BioBank collects cancer samples, normal samples, and other non-neoplastic diseases. Data available include sample-specific data, patient-specific data, and study-related data. * SOLID TISSUES (snap frozen and matched formalin-fixed paraffin embedded diseased and normal internal controls) from: Surgical resections, Image-guided biopsies, Bone marrow biopsies, Endoscopic biopsies * LIQUID TISSUES: Peripheral blood, Genomic DNA (from buffy coat), Plasma, Serum World BioBank is committed to marrying samples to a wealth of longitudinal medical data and tissue-specific data. | tissue, blood, dna, plasma, serum, snap frozen, formalin-fixed paraffin embedded, frozen, fresh, paraffin, cancer, normal, non-neoplastic disease | is listed by: One Mind Biospecimen Bank Listing | Cancer, Normal, Non-neoplastic disease | Public | nlx_92664 | SCR_004958 | 2026-02-14 02:06:21 | 0 | |||||||
|
South Carolina Biorepository System Resource Report Resource Website |
South Carolina Biorepository System (RRID:SCR_005034) | SCBS | biomaterial supply resource, tissue bank, material resource | The South Carolina Biorepository System (SCBS), directed by Dr. Phil Buckhaults, School of Medicine, is a statewide tissue bank working with health care facilities across South Carolina to collect tumor and matched normal tissue samples from patients with cancer, and providing these samples to researchers statewide. All specimens are de-identified to protect patient privacy, but are annotated with essential, detailed clinical data. Currently, the SCBS inventory includes specimens from the leading types of cancers in South Carolina: breast, colorectal, lung, and prostate, as well as many other cancer sites. The ultimate goal is to improve the lives of cancer patients and their families. | tissue, normal, tumor, tumor tissue, matched normal tissue, cancer, breast cancer, colorectal cancer, lung cancer, prostate cancer, clinical data |
is listed by: One Mind Biospecimen Bank Listing has parent organization: University of South Carolina; South Carolina; USA |
Cancer, Breast cancer, Colorectal cancer, Lung cancer, Prostate cancer | Public (South Carolina): The South Carolina Biorepository System (SCBS) is a statewide tissue bank working with health care facilities across South Carolina to collect tumor and matched normal tissue samples from patients with cancer, And providing these samples to researchers statewide. | nlx_98613 | SCR_005034 | 2026-02-14 02:05:51 | 0 |
Can't find your Tool?
We recommend that you click next to the search bar to check some helpful tips on searches and refine your search firstly. Alternatively, please register your tool with the SciCrunch Registry by adding a little information to a web form, logging in will enable users to create a provisional RRID, but it not required to submit.
Welcome to the nidm-terms Resources search. From here you can search through a compilation of resources used by nidm-terms and see how data is organized within our community.
You are currently on the Community Resources tab looking through categories and sources that nidm-terms has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.
If you have an account on nidm-terms then you can log in from here to get additional features in nidm-terms such as Collections, Saved Searches, and managing Resources.
Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:
If you are logged into nidm-terms you can add data records to your collections to create custom spreadsheets across multiple sources of data.
Here are the facets that you can filter the data by.
If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.
